HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Treatments of idiopathic sudden sensorineural hearing loss: retrospective study of 144 cases].

Abstract
In this report of a retrospective study of 144 cases of idiopathic sudden hearing loss, two important prognostic indicators appear: the elapsed time since the onset of symptoms and the degree of hearing loss. According to these indicators, the authors define three group of patients with a recovery rate of 65%: patients with a threshold hearing level of less than 40 dB, treated within two months of the onset of their hearing loss, patients with a threshold hearing level between 40 and 70 dB treated within one month and patients with a threshold hearing level of more than 70 dB treated within 7 days. Patients with a threshold hearing level of more than 70 dB, treated between 7 and 30 days, have only a partial recovery in 40%. The evaluation of efficacy of various treatment demonstrates a slight improvement of the hearing loss using steroids associated to vasodilatators, even if no significant difference is found between the different therapies. The normovolemic hemodilution and the treatment included mannitol seem to be ineffectual.
AuthorsI Mosnier, D Bouccara, M Atassi-Dumont, O Sterkers
JournalRevue de laryngologie - otologie - rhinologie (Rev Laryngol Otol Rhinol (Bord)) Vol. 119 Issue 2 Pg. 119-28 ( 1998) ISSN: 0035-1334 [Print] France
Vernacular TitleTraitements des surdités brusques: étude rétrospective de 144 cas.
PMID9770055 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Glucocorticoids
  • Vasodilator Agents
  • Mannitol
Topics
  • Adult
  • Female
  • Glucocorticoids (therapeutic use)
  • Hearing Loss, Sensorineural (drug therapy, physiopathology)
  • Hemodilution
  • Humans
  • Male
  • Mannitol (therapeutic use)
  • Prognosis
  • Retrospective Studies
  • Vasodilator Agents (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: